Management of ventricular arrhythmias in structural heart disease.

about

Management of ventricular arrhythmias in structural heart disease.

Item

http://www.wikidata.org/entity/Q38477990

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Management of ventricular arrhythmias in structural heart disease.

@en

type

Item

label

Management of ventricular arrhythmias in structural heart disease.

@en

prefLabel

Management of ventricular arrhythmias in structural heart disease.

@en

P1476

Management of ventricular arrhythmias in structural heart disease.

@en

P2093

Jason T Jacobson

http://www.w3.org/2001/XMLSchema#string

Sei Iwai

http://www.w3.org/2001/XMLSchema#string

Wilbert Aronow

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic importance of defibrillator shocks in patients with heart failure

A controlled trial of renal denervation for resistant hypertension

Efficacy of long detection interval implantable cardioverter-defibrillator settings in secondary prevention population: data from the Avoid Delivering Therapies for Nonsustained Arrhythmias in ICD Patients III (ADVANCE III) trial.

Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone.

Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease.

Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Ther

Left cardiac sympathetic denervation in the therapy of congenital long QT syndrome. A worldwide report.

Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial.

A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.

Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial.

P304

549-559

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/00325481.2015.1045816

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

127

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25971427

http://www.w3.org/2001/XMLSchema#string